Phase II Trial of Lapatinib & Capecitabine for Patients With Refractory Advanced Colorectal Adenocarcinoma
Conditions
- Metastatic Colorectal Cancer
Interventions
- DRUG: lapatinib
- DRUG: Capecitabine
Sponsor
University of Wisconsin, Madison
Collaborators